TTM Family | RayThera Acquired by Biogen for Up to $1 Billion — TTM Capital’s Second MNC Exit with the Same Founding Team Jun.24.2026
TTM Capital was rated as one of the TOP 50 Early-Stage Venture Capital Institutions in China Dec.08.2023
TTM Capital was awarded two honors by China Bridge: China's Best Return Venture Capital Institution Jan.18.2024
Synthesize Momentum, Forge Innovation | 2026 TTM Capital Investment Summit Successfully Held Mar.23.2026
